MRNA (STOCKS)
Moderna, Inc. Common Stock
$40.360000
-1.635000 (-3.89%)
Prev close: $41.995000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Stéphane Bancel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $16,204.80M
- Employees
- 5,800
- P/E (TTM)
- -5.21
- P/B (TTM)
- 1.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
3
Buy
21
Hold
3
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.51 | $-2.15 | +1.6394 | +76.27% |
|
Jun 2025 (Q2)
|
$-2.13 | $-3.03 | +0.8957 | +29.60% |
|
Mar 2025 (Q1)
|
$-2.52 | $-3.20 | +0.6787 | +21.22% |
|
Dec 2024 (Q4)
|
$-2.91 | $-2.74 | -0.1715 | -6.26% |
Financial Statements
| Revenues | $2.23B |
| Benefits Costs and Expenses | $5.39B |
| Cost Of Revenue | $1.16B |
| Costs And Expenses | $5.70B |
| Gross Profit | $1.08B |
| Operating Expenses | $4.54B |
| Research and Development | $3.48B |
| Other Operating Expenses | $1.06B |
| Operating Income/Loss | -$3.46B |
| Income/Loss Before Equity Method Investments | -$3.14B |
| Income/Loss From Continuing Operations After Tax | -$3.12B |
| Income/Loss From Continuing Operations Before Tax | -$3.15B |
| Income/Loss From Equity Method Investments | -$14.00M |
| Income Tax Expense/Benefit | -$37.00M |
| Net Income/Loss | -$3.12B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$3.12B |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.12B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$8.07 |
| Diluted Earnings Per Share | -$8.07 |
| Basic Average Shares | 1,165,000,000 |
| Diluted Average Shares | 1,165,000,000 |
| Assets | $12.14B |
| Current Assets | $6.60B |
| Inventory | $332.00M |
| Other Current Assets | $6.27B |
| Noncurrent Assets | $5.54B |
| Liabilities | $2.81B |
| Current Liabilities | $1.68B |
| Accounts Payable | $267.00M |
| Wages | $310.00M |
| Other Current Liabilities | $1.10B |
| Noncurrent Liabilities | $1.12B |
| Equity | $9.33B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.33B |
| Liabilities And Equity | $12.14B |
| Net Cash Flow From Operating Activities | -$1.98B |
| Net Cash Flow From Operating Activities, Continuing | -$1.98B |
| Net Cash Flow From Investing Activities | $1.46B |
| Net Cash Flow From Investing Activities, Continuing | $1.46B |
| Net Cash Flow From Financing Activities | $9.00M |
| Net Cash Flow From Financing Activities, Continuing | $9.00M |
| Net Cash Flow | -$513.00M |
| Net Cash Flow, Continuing | -$514.00M |
| Comprehensive Income/Loss | -$3.10B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$3.10B |
| Other Comprehensive Income/Loss | -$3.10B |
| Other Comprehensive Income/Loss Attributable To Parent | $16.00M |